A recent study, presented at the EuroCMR 2017 Congress, tested whether statin therapy was associated with positive changes in the hearts of participants from the UK Biobank.
A new study sought to determine the ability of the new QRISK3 model, which includes new risk factors, to calculate cardiovascular disease risk in a cohort of over 7 million patients.
A new study sought to determine the ability of the new QRISK3 model, which includes new risk factors, to calculate cardiovascular disease risk in a cohort of over 7 million patients.
In a new study, researchers examined how trends in high-intensity statin use may have changed in recent years due to updated guidelines, black box warnings, and the availability of generic atorvastatin.
...
A recent study investigated the impact of glycated hemoglobin and plasma glucose concentration variations on cardiovascular disease risk in individuals with impaired glucose metabolism.
A recent study investigated the impact of glycated hemoglobin and plasma glucose concentration variations on cardiovascular disease risk in individuals with impaired glucose metabolism.